Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Safety and Efficacy of MRI Scans in Patients With Implanted Microvascular Coupling Devices.

Phalke N, Thomas WW, Azzi J, Li RJ, Petrisor D, Wax MK.

Laryngoscope. 2019 Sep 13. doi: 10.1002/lary.28275. [Epub ahead of print]

PMID:
31517990
2.

Postoperative infection predicts poor survival in locoregionally advanced oral cancer.

Mascarella MA, Azzi JL, da Silva SD, Mlynarek A, Forest VI, Hier M, Richardson K, Sadeghi N.

Head Neck. 2019 Oct;41(10):3624-3630. doi: 10.1002/hed.25885. Epub 2019 Aug 5.

PMID:
31385387
3.

Conversion from tacrolimus to belatacept improves renal function in kidney transplant patients with chronic vascular lesions in allograft biopsy.

Pérez-Sáez MJ, Yu B, Uffing A, Murakami N, Borges TJ, Azzi J, El Haji S, Gabardi S, Riella LV.

Clin Kidney J. 2018 Dec 1;12(4):586-591. doi: 10.1093/ckj/sfy115. eCollection 2019 Aug.

4.

First Report of Perfluorobutane Microsphere-Enhanced Ultrasound in the Transplant Kidney.

Siedlecki AM, Benson C, Frates M, Azzi J, Hoffman RJ, Milford E, Weins A, Chandraker A, Mc Donald N, Philip White J, Abdi R.

Transplantation. 2019 Oct;103(10):e283-e284. doi: 10.1097/TP.0000000000002856. No abstract available.

PMID:
31335773
5.

Incidence of inadequate perforators and salvage options for the anterior lateral thigh free flap.

Thomas WW, Calcagno HE, Azzi J, Petrisor D, Cave T, Barber B, Miles B, Gomez ED, Cannady S, Bhadkamkar M, Hanasono MM, Wax MK.

Laryngoscope. 2019 Jul 4. doi: 10.1002/lary.28176. [Epub ahead of print]

PMID:
31271453
6.

Notch-1 Inhibition Promotes Immune Regulation in Transplantation Via Regulatory T Cell-Dependent Mechanisms.

Magee CN, Murakami N, Borges TJ, Shimizu T, Safa K, Ohori S, Cai S, Uffing A, Azzi J, Elyaman W, Charbonnier LM, Liu K, Toprak D, Visner G, Chatila TA, Siebel CW, Najafian N, Riella LV.

Circulation. 2019 Sep 9;140(10):846-863. doi: 10.1161/CIRCULATIONAHA.119.040563. Epub 2019 Jul 3.

PMID:
31266349
7.

Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation.

Uffing A, Hidalgo LG, McMullan C, Perry J, Milford EL, Murakami N, Yeung MY, Guleria I, Wood IG, Akalin E, Azzi J, Chandraker AK, Riella LV.

Transplant Direct. 2019 Apr 15;5(5):e446. doi: 10.1097/TXD.0000000000000893. eCollection 2019 May.

8.

MEDTalks: a student-driven program to enhance undergraduate student understanding and interest in medical schools in Canada.

Azzi J, Karol D, Bailey T, Ramnanan CJ.

J Educ Eval Health Prof. 2019;16:13. doi: 10.3352/jeehp.2019.16.13. Epub 2019 May 22.

9.

Quantifying circulating cell-free DNA in humans.

Meddeb R, Dache ZAA, Thezenas S, Otandault A, Tanos R, Pastor B, Sanchez C, Azzi J, Tousch G, Azan S, Mollevi C, Adenis A, El Messaoudi S, Blache P, Thierry AR.

Sci Rep. 2019 Mar 26;9(1):5220. doi: 10.1038/s41598-019-41593-4.

10.

Outstanding questions in transplantation: An introduction to this minireview series.

Azzi J, Alegre ML.

Am J Transplant. 2019 Aug;19(8):2149-2150. doi: 10.1111/ajt.15367. Epub 2019 Apr 15. No abstract available.

PMID:
30903734
11.

Early Identification of Patients Who Will Meet 24-Hour Fluid Output Threshold for Chest Tube Removal After Lung Resection.

Azzi JL, Gottlieb B, Maziak DE, Seely AJE, Shamji FM, Sundaresan S, Villeneuve PJ, Gilbert S.

Semin Thorac Cardiovasc Surg. 2019 Feb 21. pii: S1043-0679(19)30075-9. doi: 10.1053/j.semtcvs.2019.02.023. [Epub ahead of print]

PMID:
30797904
12.

Biomarkers in Solid Organ Transplantation.

Choi J, Bano A, Azzi J.

Clin Lab Med. 2019 Mar;39(1):73-85. doi: 10.1016/j.cll.2018.11.003. Epub 2018 Dec 17. Review.

PMID:
30709510
13.

Regulatory T Cells for More Targeted Immunosuppressive Therapies.

Allos H, Al Dulaijan BS, Choi J, Azzi J.

Clin Lab Med. 2019 Mar;39(1):1-13. doi: 10.1016/j.cll.2018.11.001. Epub 2018 Dec 20. Review.

PMID:
30709499
14.

[Genetic and transcriptional evolution alters cancer cell line drug response].

Pourquier P, Azzi J.

Bull Cancer. 2019 Jan;106(1):9-10. doi: 10.1016/j.bulcan.2018.12.002. Epub 2018 Dec 27. French. No abstract available.

PMID:
30595222
15.

Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients.

Sheshadri A, Chemaly RF, Alousi AM, Shah PK, Rondon G, Bashoura L, Kmeid J, Azzi J, Blanco DW, Kaous M, Dickey BF, Champlin RE, Shah DP.

Biol Blood Marrow Transplant. 2019 Apr;25(4):800-809. doi: 10.1016/j.bbmt.2018.11.022. Epub 2018 Dec 3.

PMID:
30521974
16.

Targeting antigen-presenting cells by anti-PD-1 nanoparticles augments antitumor immunity.

Ordikhani F, Uehara M, Kasinath V, Dai L, Eskandari SK, Bahmani B, Yonar M, Azzi JR, Haik Y, Sage PT, Murphy GF, Annabi N, Schatton T, Guleria I, Abdi R.

JCI Insight. 2018 Oct 18;3(20). pii: 122700. doi: 10.1172/jci.insight.122700.

17.

Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival.

Bahmani B, Uehara M, Jiang L, Ordikhani F, Banouni N, Ichimura T, Solhjou Z, Furtmüller GJ, Brandacher G, Alvarez D, von Andrian UH, Uchimura K, Xu Q, Vohra I, Yilmam OA, Haik Y, Azzi J, Kasinath V, Bromberg JS, McGrath MM, Abdi R.

J Clin Invest. 2018 Nov 1;128(11):4770-4786. doi: 10.1172/JCI120923. Epub 2018 Oct 2.

18.

New Treatment Algorithms in Hodgkin Lymphoma: Too Much or Too Little?

Spinner MA, Advani RH, Connors JM, Azzi J, Diefenbach C.

Am Soc Clin Oncol Educ Book. 2018 May 23;38:626-636. doi: 10.1200/EDBK_200679. Review.

PMID:
30231319
19.

Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.

Vakil E, Sheshadri A, Faiz SA, Shah DP, Zhu Y, Li L, Kmeid J, Azzi J, Balagani A, Bashoura L, Ariza-Heredia E, Chemaly RF.

Transpl Infect Dis. 2018 Dec;20(6):e12994. doi: 10.1111/tid.12994. Epub 2018 Sep 21.

PMID:
30195271
20.

March1-dependent modulation of donor MHC II on CD103+ dendritic cells mitigates alloimmunity.

Borges TJ, Murakami N, Machado FD, Murshid A, Lang BJ, Lopes RL, Bellan LM, Uehara M, Antunes KH, Pérez-Saéz MJ, Birrane G, Vianna P, Gonçalves JIB, Zanin RF, Azzi J, Abdi R, Ishido S, Shin JS, Souza APD, Calderwood SK, Riella LV, Bonorino C.

Nat Commun. 2018 Aug 28;9(1):3482. doi: 10.1038/s41467-018-05572-z.

21.

Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection.

Azzi JM, Kyvernitakis A, Shah DP, El Haddad L, Mahajan SN, Ghantoji SS, Heredia-Ariza E, Chemaly RF.

J Antimicrob Chemother. 2018 Nov 1;73(11):3162-3169. doi: 10.1093/jac/dky311.

PMID:
30113677
22.

Perioperative considerations in free flap surgery: A review of pressors and anticoagulation.

Wax MK, Azzi J.

Oral Oncol. 2018 Aug;83:154-157. doi: 10.1016/j.oraloncology.2018.06.025. Epub 2018 Jun 28.

PMID:
30098772
23.

Resorbable Material for Pediatric Orbital Floor Reconstruction.

Azzi J, Azzi AJ, Cugno S.

J Craniofac Surg. 2018 Oct;29(7):1693-1696. doi: 10.1097/SCS.0000000000004630.

PMID:
29863555
24.

Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab.

Kurdi AT, Glavey SV, Bezman NA, Jhatakia A, Guerriero JL, Manier S, Moschetta M, Mishima Y, Roccaro A, Detappe A, Liu CJ, Sacco A, Huynh D, Tai YT, Robbins MD, Azzi J, Ghobrial IM.

Mol Cancer Ther. 2018 Jul;17(7):1454-1463. doi: 10.1158/1535-7163.MCT-17-0998. Epub 2018 Apr 13.

25.

First evaluation of drug-in-cyclodextrin-in-liposomes as an encapsulating system for nerolidol.

Azzi J, Auezova L, Danjou PE, Fourmentin S, Greige-Gerges H.

Food Chem. 2018 Jul 30;255:399-404. doi: 10.1016/j.foodchem.2018.02.055. Epub 2018 Feb 16.

PMID:
29571492
26.

Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression.

Kawano Y, Zavidij O, Park J, Moschetta M, Kokubun K, Mouhieddine TH, Manier S, Mishima Y, Murakami N, Bustoros M, Pistofidis RS, Reidy M, Shen YJ, Rahmat M, Lukyanchykov P, Karreci ES, Tsukamoto S, Shi J, Takagi S, Huynh D, Sacco A, Tai YT, Chesi M, Bergsagel PL, Roccaro AM, Azzi J, Ghobrial IM.

J Clin Invest. 2018 Jun 1;128(6):2487-2499. doi: 10.1172/JCI88169. Epub 2018 May 14.

27.

Regulatory T cells: from the bench to the clinic and back.

Al Dulaijan BS, Mansouri A, Karnyski J, Azzi J.

Curr Opin Organ Transplant. 2018 Feb;23(1):1-7. doi: 10.1097/MOT.0000000000000491. Review.

PMID:
29210727
28.

Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes.

Santos RLA, Bai L, Singh PK, Murakami N, Fan H, Zhan W, Zhu Y, Jiang X, Zhang K, Assker JP, Nathan CF, Li H, Azzi J, Lin G.

Nat Commun. 2017 Nov 22;8(1):1692. doi: 10.1038/s41467-017-01760-5.

29.

Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation.

Sula Karreci E, Eskandari SK, Dotiwala F, Routray SK, Kurdi AT, Assaker JP, Luckyanchykov P, Mihali AB, Maarouf O, Borges TJ, Alkhudhayri A, Patel KR, Radwan A, Ghobrial I, McGrath M, Chandraker A, Riella LV, Elyaman W, Abdi R, Lieberman J, Azzi J.

JCI Insight. 2017 Nov 2;2(21). pii: 91599. doi: 10.1172/jci.insight.91599.

30.

Integrated Kidney Exosome Analysis for the Detection of Kidney Transplant Rejection.

Park J, Lin HY, Assaker JP, Jeong S, Huang CH, Kurdi T, Lee K, Fraser K, Min C, Eskandari S, Routray S, Tannous B, Abdi R, Riella L, Chandraker A, Castro CM, Weissleder R, Lee H, Azzi JR.

ACS Nano. 2017 Nov 28;11(11):11041-11046. doi: 10.1021/acsnano.7b05083. Epub 2017 Oct 25.

31.

Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ.

Uehara M, McGrath MM, Ohori S, Solhjou Z, Banouni N, Routray S, Evans C, DiNitto JP, Elkhal A, Turka LA, Strom TB, Tullius SG, Winkler DG, Azzi J, Abdi R.

Nat Commun. 2017 Oct 16;8(1):951. doi: 10.1038/s41467-017-00982-x.

32.

A critical review of biomarkers in kidney transplantation.

Safa K, Magee CN, Azzi J.

Curr Opin Nephrol Hypertens. 2017 Nov;26(6):509-515. doi: 10.1097/MNH.0000000000000361. Review.

PMID:
28857783
33.

The outstanding questions in transplantation: It's about time….

Azzi J, Raimondi G, Mas V, Riella LV, Elfadawy N, Safa K, Wojciechowski D, Kanak M, Nog R, Maltzman JS, Ford ML, Pober JS, Luo XR, Rothstein D, Miller ML, Matthews D, Burlingham W, Levings M, Heeger P, Higdon L, Gill J, Gill RG, Alegre ML.

Am J Transplant. 2018 Jan;18(1):271-272. doi: 10.1111/ajt.14450. Epub 2017 Sep 2. No abstract available.

34.

The immunoproteasome: An old player with a novel and emerging role in alloimmunity.

Eskandari SK, Seelen MAJ, Lin G, Azzi JR.

Am J Transplant. 2017 Dec;17(12):3033-3039. doi: 10.1111/ajt.14435. Epub 2017 Aug 30. Review.

35.

CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.

Mallat SG, Tanios BY, Itani HS, Lotfi T, McMullan C, Gabardi S, Akl EA, Azzi JR.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1321-1336. doi: 10.2215/CJN.13221216. Epub 2017 Jun 2. Review.

36.

The effect of cyclodextrin complexation on the solubility and photostability of nerolidol as pure compound and as main constituent of cabreuva essential oil.

Azzi J, Danjou PE, Landy D, Ruellan S, Auezova L, Greige-Gerges H, Fourmentin S.

Beilstein J Org Chem. 2017 May 5;13:835-844. doi: 10.3762/bjoc.13.84. eCollection 2017.

37.

Multiple Myeloma and the Immune Microenvironment.

Kawano Y, Roccaro AM, Ghobrial IM, Azzi J.

Curr Cancer Drug Targets. 2017;17(9):806-818. doi: 10.2174/1568009617666170214102301. Review.

PMID:
28201978
38.

PI3Kγ Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells.

Azzi J, Thueson L, Moore R, Abdoli R, Reijonen H, Abdi R.

PLoS One. 2017 Jan 12;12(1):e0169695. doi: 10.1371/journal.pone.0169695. eCollection 2017.

39.

Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice.

Sula Karreci E, Fan H, Uehara M, Mihali AB, Singh PK, Kurdi AT, Solhjou Z, Riella LV, Ghobrial I, Laragione T, Routray S, Assaker JP, Wang R, Sukenick G, Shi L, Barrat FJ, Nathan CF, Lin G, Azzi J.

Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):E8425-E8432. doi: 10.1073/pnas.1618548114. Epub 2016 Dec 12.

40.

Cholinergic Stimulation Prevents the Development of Autoimmune Diabetes: Evidence for the Modulation of Th17 Effector Cells via an IFNγ-Dependent Mechanism.

George JA, Bashir G, Qureshi MM, Mohamed YA, Azzi J, Al-Ramadi BK, Fernández-Cabezudo MJ.

Front Immunol. 2016 Oct 13;7:419. eCollection 2016.

41.
42.

Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients.

Langman LJ, Nesher L, Shah DP, Azzi JM, Shpall EJ, Rezvani K, Black JL 3rd, Chemaly RF.

J Mol Diagn. 2016 Sep;18(5):638-642. doi: 10.1016/j.jmoldx.2016.03.007. Epub 2016 Jun 29.

43.

Belatacept and Long-Term Outcomes in Kidney Transplantation.

Riella LV, Gabardi S, Azzi J.

N Engl J Med. 2016 Jun 30;374(26):2599-600. doi: 10.1056/NEJMc1602859. No abstract available.

PMID:
27355545
44.

Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review.

Shah DP, Shah PK, Azzi JM, El Chaer F, Chemaly RF.

Cancer Lett. 2016 Aug 28;379(1):100-6. doi: 10.1016/j.canlet.2016.05.035. Epub 2016 May 31. Review.

45.

Mitochondrial Dynamics Impacts Stem Cell Identity and Fate Decisions by Regulating a Nuclear Transcriptional Program.

Khacho M, Clark A, Svoboda DS, Azzi J, MacLaurin JG, Meghaizel C, Sesaki H, Lagace DC, Germain M, Harper ME, Park DS, Slack RS.

Cell Stem Cell. 2016 Aug 4;19(2):232-247. doi: 10.1016/j.stem.2016.04.015. Epub 2016 May 26.

46.

Targeted Delivery of Immunomodulators to Lymph Nodes.

Azzi J, Yin Q, Uehara M, Ohori S, Tang L, Cai K, Ichimura T, McGrath M, Maarouf O, Kefaloyianni E, Loughhead S, Petr J, Sun Q, Kwon M, Tullius S, von Andrian UH, Cheng J, Abdi R.

Cell Rep. 2016 May 10;15(6):1202-13. doi: 10.1016/j.celrep.2016.04.007. Epub 2016 Apr 28.

47.

Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients.

Nesher L, Shah DP, Ariza-Heredia EJ, Azzi JM, Siddiqui HK, Ghantoji SS, Marsh LY, Michailidis L, Makedonas G, Rezvani K, Shpall EJ, Chemaly RF.

J Infect Dis. 2016 Jun 1;213(11):1701-7. doi: 10.1093/infdis/jiw064. Epub 2016 Feb 11.

48.

Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.

Karia PS, Azzi JR, Heher EC, Hills VM, Schmults CD.

JAMA Dermatol. 2016 May 1;152(5):533-40. doi: 10.1001/jamadermatol.2015.5548.

PMID:
26792250
49.

Codominant Role of Interferon-γ- and Interleukin-17-Producing T Cells During Rejection in Full Facial Transplant Recipients.

Borges TJ, O'Malley JT, Wo L, Murakami N, Smith B, Azzi J, Tripathi S, Lane JD, Bueno EM, Clark RA, Tullius SG, Chandraker A, Lian CG, Murphy GF, Strom TB, Pomahac B, Najafian N, Riella LV.

Am J Transplant. 2016 Jul;16(7):2158-71. doi: 10.1111/ajt.13705. Epub 2016 Apr 7.

50.

Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index.

Kmeid J, Vanichanan J, Shah DP, El Chaer F, Azzi J, Ariza-Heredia EJ, Hosing C, Mulanovich V, Chemaly RF.

Biol Blood Marrow Transplant. 2016 Mar;22(3):542-8. doi: 10.1016/j.bbmt.2015.11.015. Epub 2015 Nov 27.

Supplemental Content

Support Center